These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14390431)

  • 21. [Preparation of anti-erythrocytic serum (anti-H) by immunization of goat with Shigella dysenteriae].
    FORMAGGIO TG; DE FILIPPIS V
    Boll Ist Sieroter Milan; 1954; 33(5-6):282-91. PubMed ID: 13199106
    [No Abstract]   [Full Text] [Related]  

  • 22. Dynamics of intestinal flora after oral vaccination with inactivated whole-cell/recombinant B subunit O139 cholera vaccine.
    Wu HX; Chen Q; Li JD; Huang XF
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):220-2, 225. PubMed ID: 14965834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shigellosis: the current status of vaccine development.
    Kweon MN
    Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Willingness to be vaccinated against shigella and other forms of dysentery: a comparison of three regions in Asia.
    Pack R; Wang Y; Singh A; von Seidlein L; Pach A; Kaljee L; Butraporn P; Youlong G; Blum L; Bhutta Z; Santoso SS; Trach DD; Waluyo I; Nyamete A; Clemens J; Stanton B
    Vaccine; 2006 Jan; 24(4):485-94. PubMed ID: 16137802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current aspects of Shigella pathogenesis.
    Torres AG
    Rev Latinoam Microbiol; 2004; 46(3-4):89-97. PubMed ID: 17061529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of intestinal secretion by vasoactive intestinal peptide and cholera toxin.
    Burleigh DE; Banks MR
    Auton Neurosci; 2007 Apr; 133(1):64-75. PubMed ID: 17023221
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shigella flexneri infection is dependent on villin in the mouse intestine and in primary cultures of intestinal epithelial cells.
    Athman R; Fernandez MI; Gounon P; Sansonetti P; Louvard D; Philpott D; Robine S
    Cell Microbiol; 2005 Aug; 7(8):1109-16. PubMed ID: 16008578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of vascular reflexes from intestinal chemoreceptors in experimental intestinal obstruction].
    LEBEDEVA VA
    Biull Eksp Biol Med; 1955 Jan; 39(1):22-7. PubMed ID: 14378221
    [No Abstract]   [Full Text] [Related]  

  • 30. Reaching a consensus on management practices and vaccine development targets for mitigation of infectious diarrhoea among deployed US military forces.
    Riddle MS; Tribble DR
    J Eval Clin Pract; 2008 Apr; 14(2):266-74. PubMed ID: 18284518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Certain morphological changes in isolated intestinal segments following their denervation].
    NILOVA NA; FOMINA LS
    Biull Eksp Biol Med; 1958 Mar; 45(3):110-4. PubMed ID: 13535888
    [No Abstract]   [Full Text] [Related]  

  • 32. The versatility of Shigella effectors.
    Ogawa M; Handa Y; Ashida H; Suzuki M; Sasakawa C
    Nat Rev Microbiol; 2008 Jan; 6(1):11-6. PubMed ID: 18059288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New vaccines against enteric bacteria for children in less developed countries.
    Walker RI
    Expert Rev Vaccines; 2005 Dec; 4(6):807-12. PubMed ID: 16372876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STUDIES IN THE PATHOGENESIS OF EXPERIMENTAL DYSENTERY INTOXICATION.
    Penner A; Bernheim AI
    J Exp Med; 1942 Sep; 76(3):271-82. PubMed ID: 19871235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electrophysiological investigation on the mechanism of chemoreception. III. Effect of nicotine and acids on intestinal receptors in monoiodoacetic acid metabolism disorders].
    ANIKINA NA
    Biull Eksp Biol Med; 1958 Jun; 45(6):11-6. PubMed ID: 13560536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electrophysiologic characteristics and functional significance of afferent impulses from the receptors of the intestinal wall].
    ZAMIATINA ON
    Tr Inst Fiziol Im I P Pavlova; 1954; 3():193-208. PubMed ID: 14386490
    [No Abstract]   [Full Text] [Related]  

  • 38. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination against salmonella, enterohaemorrhagic E. coli and Campylobacter in food-producing animals.
    Wallis TS
    Dev Biol (Basel); 2004; 119():343-50. PubMed ID: 15742645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunologic reaction in dysentery peculiar to various age groups].
    OVSIEVSKAIA IV
    Pediatriia; 1956; 39(3):20-5. PubMed ID: 13370258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.